Honors & Awards |The strength of scientific and technological innovation has been officially recognized! Haier Biomedical won two major awardsIntroduction
The ability of scientific and technological innovation is the core of enterprise development ability, adaptability and competitiveness, and the support of the comprehensive strength of the enterprise. As a national enterprise, Haier Biomedical has taken advantage of the changes of the times and continued to release the vitality of independent innovation, and its scientific and technological innovation strength and brand strength have been frequently officially recognized!
Next, let's take a look at the recent awards
Digital and intelligent innovation in vaccination
Won the second prize of Qingdao Science and Technology Progress Award
A few days ago, the 2023 Qingdao Science and Technology Award Review Committee ended its review. In the list of winners announced, Qingdao Haier Biomedical's *** project "Innovation and Application of Intelligent Vaccination Model Based on Internet of Things Technology" won the second prize of Qingdao Science and Technology Progress Award in 2023. Behind the honor, it is an important embodiment of Haier Biomedical's strategic transformation based on the Internet of Things and digital and intelligent innovation, and it also reflects the responsibility and responsibility of the enterprise to benefit the people with science and technology.
It is understood that in the field of vaccination, Haier Biomedical integrates emerging technologies such as the Internet of Things, big data, and 5G, and innovatively launches the "Digital Vaccine Full-Scenario Solution" to realize the "community + mobile" vaccine full-scene smart vaccination, which can not only build a solid immune barrier and ensure the safety of residents' vaccination, but also allow "the vaccine to run more and the masses to run less errands", truly opening up the "last mile" of serving the masses of vaccination.
Scientific and technological innovation serves the national strategy
It was selected as a leading private benchmarking enterprise in Qingdao
In order to accelerate the creation of a world-class enterprise with global competitiveness and create a benchmark demonstration of high-quality development of the private economy, the Qingdao Private Economic Development Bureau organized and launched the "2023 Qingdao Private Leading Benchmarking Enterprise" selection activity. Among them, Haier Biomedical was successfully selected, which means that the company's industry status, innovation and development, and brand strength have been highly recognized, and it has established its leading position in helping the high-quality development of the private economy in the whole country.
For a long time, Haier Biomedical has insisted on integrating emerging technologies such as the Internet of Things, big data, and 5G into the national strategy of scene services. Focusing on the needs of the rapid development of the life sciences field, Haier Biomedical Innovation Smart Laboratory, Biobank and other scenario solutions continue to serve China's major national strategic projects such as biosecurity, biodiversity, and food security. Focusing on the life and health needs of the people, we have launched scenario solutions such as smart blood, smart hospitals, and smart public health, injecting a steady stream of scientific and technological strength into the Healthy China strategy.
Honor is not only an affirmation of the company's past achievements, but also a spur and driving force for future development. As an ecological brand of digital scenarios for life science and medical innovation, Haier Biomedical will adhere to independent scientific and technological innovation as the background and digital and intelligent innovation as the path, continuously develop new products and solutions, contribute to economic and social development and people's life progress, and make life better.